Assignee
UNIV HEIDELBERG
DE·22 granted patents·45 pending applications·93 citations·filing 1995–2025
Top patents by PatentIndex Score
67 records- 0190US10481095B2Methods and means for multispectral imagingUNIV HEIDELBERG·Filed 2015·Granted Nov 19, 2019·16 cites·17 claims
- 0287US5912411AMice transgenic for a tetracycline-inducible transcriptional activatorUNIV HEIDELBERG·Filed 1995·Granted Jun 15, 1999·64 cites·36 claims
- 0385US10684224B2Method and means for multispectral imagingUNIV HEIDELBERG·Filed 2015·Granted Jun 16, 2020·5 cites·20 claims
- 0479US2025127937A1Fap inhibitorUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0574US2025057993A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0671US2024299538A1Agent for use in the treatment of gliomaUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0771US2023112012A1Fap inhibitorUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 0870US2026000754A1Nanoparticles as carrier-system for adjuvants/antigensUNIV HEIDELBERG·Filed 2025·Application pending·0 cites
- 0969US11181532B2Delta-like ligand 1 for diagnosing severe infectionsUNIV HEIDELBERG·Filed 2018·Granted Nov 23, 2021·1 cites·16 claims
- 1067US2024025960A1Rage proteins for the treatment of fibrosis and dna damage mediated diseasesUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 1165US2021038749A1Fap inhibitorUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 1262US11841368B2Method and means for the rapid detection of HDV infectionsUNIV HEIDELBERG·Filed 2019·Granted Dec 12, 2023·0 cites·20 claims
- 1362US2026055441A1A pcr-elisa analogous antibody-free method for detecting a target nucleic acid in a sampleUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 1460US2024200045A1Nuclease with improved targeting activityUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1558US2025006368A1Sampling interval adjusted classification toolUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1658US2026058010A1Method for classification of cancerUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1757US2023151054A1Sulfur extrusion from disulfides by carbenesUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 1857US2023352149A1Single-cell morphology analysis for disease profiling and drug discoveryUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 1956US12448606B2Assay for FGF2 secretion and signalingUNIV HEIDELBERG·Filed 2021·Granted Oct 21, 2025·0 cites·8 claims
- 2056US2025206780A1Cyclic peptides and their use for the treatment of diseases associated with dicarbonyls like methylglyoxalUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 2156US2025138206A1Sensor data processing module and method thereofUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 2255US2019323926A1Use of a plastic film in the field of light microscopyUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 2355US2024350250A1Endograft Device For Treating Ruptures In A Blood VesselUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 2454US2023183805A1Residual enzyme activity in metabolic diseaseUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2553US11618773B2NFAT binding polynucleotidesUNIV HEIDELBERG·Filed 2019·Granted Apr 4, 2023·0 cites·15 claims
- 2653US2022127678A1Biomarker panel for diagnosis and prognosis of cancerUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2753US2023211003A1Conjugate compounds for preventing and/or treating hbv and/or hdv infections, liver diseases andfor targeting ntcpUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2853US2022008508A1Relaxin receptor 1 for use in treatment and prevention of heart failureUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 2952US11123368B2Immunosuppressive blood cells and methods of producing the sameUNIV HEIDELBERG·Filed 2017·Granted Sep 21, 2021·0 cites·18 claims
- 3052US2022268770A13d-1d multidimensional cancer-on-a-chipUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 3149US2025052768A1In vitro methods for detecting dll1UNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 3248US2020140518A1Rage proteins for the treatment of fibrosis and dna damage mediated diseasesUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 3347US11835405B2Force measuring disc and device for determining forces in the pico-newton to nano-newton rangeUNIV HEIDELBERG·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
- 3447US10842793B2Inhibitors of the unconventional secretion of fibroblast growth factor 2 (FGF2) by tumor cells and uses thereofUNIV HEIDELBERG·Filed 2017·Granted Nov 24, 2020·0 cites·9 claims
- 3547US10155041B2Bacterial phospholipase inhibitors as modulator of colonic bacterial floraUNIV HEIDELBERG·Filed 2015·Granted Dec 18, 2018·0 cites·13 claims
- 3647US2010160230A1Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune systemUNIV HEIDELBERG·Filed 2009·Application pending·0 cites
- 3747US2023107186A1Cobicistat for prevention and/or treatment of coronavirus infectionsUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 3847US2021363193A1Modified aav capsid polypeptides for treatment of muscular diseasesUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 3947US2020368211A1Inhibition of gamma-glutamyltransferase and glutathione catabolism to enhance the efficacy of nf-kb signalling pathway inhibitorsUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 4045US2017043026A1Bacterial phospholipase inhibitors as modulator of colonic bacterial floraUNIV HEIDELBERG·Filed 2016·Application pending·0 cites
- 4144US2022381770A1Artificial antigen presenting molecules and their usesUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 4244US2023105111A1System and Method for Teaching Minimally Invasive InterventionsUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 4343US12544485B2Method to prevent propagation of irregular electromechanical waves in the myocardium by creating lines of increased tissue conductivityUNIV HEIDELBERG·Filed 2019·Granted Feb 10, 2026·0 cites·13 claims
- 4443US11555063B2Norovirus antibodiesUNIV HEIDELBERG·Filed 2018·Granted Jan 17, 2023·0 cites·12 claims
- 4543US6384300B1Invertase inhibitorUNIV HEIDELBERG·Filed 1997·Granted May 7, 2002·7 cites·22 claims
- 4642US2022111013A1Compound decreasing the concentration of 2-hydroxy-glutarateUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 4741US2021198328A1Modulated cas-inhibitorsUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 4841US2023241233A1Oral pharmaceutical compositions comprising lipid conjugatesUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 4940US10653796B2Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromoleculesUNIV HEIDELBERG·Filed 2016·Granted May 19, 2020·0 cites·13 claims
- 5040US2024358494A1Perivascular implantUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →